UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Predicting treatment benefit in multiple myeloma through simulation of alternative treatment effects

Nature communications, 2018-07, Vol.9 (1), p.2943-10, Article 2943

2018

Volltextzugriff (PDF)

Array-CGH and breast cancer

Breast cancer research : BCR, 2006-01, Vol.8 (3), p.210-210, Article 210

2006

Volltextzugriff (PDF)

Analysis of PALB2/FANCN-associated breast cancer families

Proceedings of the National Academy of Sciences - PNAS, 2007-04, Vol.104 (16), p.6788-6793

2007

Volltextzugriff (PDF)

Prediction of high- and low-risk multiple myeloma based on gene expression and the International Staging System

Blood, 2015-10, Vol.126 (17), p.1996-2004

2015

Volltextzugriff (PDF)

Automated array-CGH optimized for archival formalin-fixed, paraffin-embedded tumor material

BMC cancer, 2007-03, Vol.7 (1), p.43-43, Article 43

2007

Volltextzugriff (PDF)

Analytical Validation of SKY92 for the Identification of High-Risk Multiple Myeloma

The Journal of molecular diagnostics : JMD, 2021-01, Vol.23 (1), p.120-129

2021

Volltextzugriff (PDF)

Prognostic gene expression analysis in a retrospective, multinational cohort of 155 multiple myeloma patients treated outside clinical trials

International journal of laboratory hematology, 2022-02, Vol.44 (1), p.127-134

2022

Volltextzugriff (PDF)

Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH

Breast cancer research and treatment, 2009-08, Vol.116 (3), p.479-489

2009

Volltextzugriff (PDF)

Prognostic and predictive performance of R-ISS with SKY92 in older patients with multiple myeloma: the HOVON-87/NMSG-18 trial

Blood advances, 2020-12, Vol.4 (24), p.6298-6309

2020

Volltextzugriff (PDF)

A standardized microarray assay for the independent gene expression markers in AML: EVI1 and BAALC

Experimental hematology & oncology, 2013-03, Vol.2 (1), p.7-7, Article 7

2013

Volltextzugriff (PDF)

Prognostic Validation of SKY92 and Its Combination With ISS in an Independent Cohort of Patients With Multiple Myeloma

Clinical lymphoma, myeloma and leukemia, 2017-09, Vol.17 (9), p.555-562

2017

Volltextzugriff (PDF)

Potential therapeutic and economic value of risk-stratified treatment as initial treatment of multiple myeloma in Europe

Pharmacogenomics, 2018-02, Vol.19 (3), p.213-226

2018

Volltextzugriff (PDF)

Genome-wide linkage scan in Dutch hereditary non-BRCA1/2 breast cancer families identifies 9q21-22 as a putative breast cancer susceptibility locus

Genes chromosomes & cancer, 2008-11, Vol.47 (11), p.947-956

2008

Volltextzugriff (PDF)

Integration of DNA Copy Number Alterations and Prognostic Gene Expression Signatures in Breast Cancer Patients

Clinical cancer research, 2010-01, Vol.16 (2), p.651-663

2010

Volltextzugriff (PDF)

Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations

Cancer research (Chicago, Ill.), 2005-02, Vol.65 (3), p.822-827

2005

Volltextzugriff (PDF)

Cross-species comparison of aCGH data from mouse and human BRCA1- and BRCA2-mutated breast cancers

BMC cancer, 2010-08, Vol.10 (1), p.455-455, Article 455

2010

Volltextzugriff (PDF)

Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket : a multi-modal approach

European journal of human genetics : EJHG, 2008-07, Vol.16 (7), p.820-832

2008

Volltextzugriff (PDF)

Retreat to make progress

Nature (London), 2005-11, Vol.438 (7064), p.126-126

2005

Volltextzugriff (PDF)

Detection of mutant NPM1 mRNA in acute myeloid leukemia using custom gene expression arrays

Genetic testing and molecular biomarkers, 2013-04, Vol.17 (4), p.295-300

2013

Volltextzugriff (PDF)

Detection of CEBPA double mutants in acute myeloid leukemia using a custom gene expression array

Genetic testing and molecular biomarkers, 2013-05, Vol.17 (5), p.395-400

2013

Volltextzugriff (PDF)

The Prognostic Power of Gene Expression Profiling with Cytogentics and Routinely Acquired Serum Markers: SKY92 Combined with Revised ISS

Blood, 2020-11, Vol.136 (Supplement 1), p.24-25

2020

Volltextzugriff (PDF)

High-Risk Multiple Myeloma Patients Are Missed without Gene Expression Profiling

Blood, 2020-11, Vol.136 (Supplement 1), p.23-24

2020

Volltextzugriff (PDF)

The Combination of SKY92 and ISS Provides a Powerful Tool to Identify Both High Risk and Low Risk Multiple Myeloma Cases, Validation in Two Independent Cohorts

Blood, 2015-12, Vol.126 (23), p.2970-2970

2015

Volltextzugriff (PDF)

Validation of SKY92 high and low risk prognostication in a retrospective, multinational cohort of 155 non-trial multiple myeloma patients

Clinical lymphoma, myeloma and leukemia, 2019-10, Vol.19 (10), p.e60-e61

2019

Volltextzugriff (PDF)

Comprehensive Biologic Characterization of 99 Multiple Myeloma Patients Using Cytomorphology, FISH, Gene Expression Profiling and Mutation Screening Leads to Important Clinical and Therapeutic Insights

Blood, 2016-12, Vol.128 (22), p.4424-4424

2016

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(70)

Publikationsform

Sprache

Englisch
(76)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Predicting treatment benefit in multiple myeloma through simulation of alternative treatment effects

Array-CGH and breast cancer

Analysis of PALB2/FANCN-associated breast cancer families

Prediction of high- and low-risk multiple myeloma based on gene expression and the International Staging System

Automated array-CGH optimized for archival formalin-fixed, paraffin-embedded tumor material

Analytical Validation of SKY92 for the Identification of High-Risk Multiple Myeloma

Prognostic gene expression analysis in a retrospective, multinational cohort of 155 multiple myeloma patients treated outside clinical trials

Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH

Prognostic and predictive performance of R-ISS with SKY92 in older patients with multiple myeloma: the HOVON-87/NMSG-18 trial

A standardized microarray assay for the independent gene expression markers in AML: EVI1 and BAALC

Prognostic Validation of SKY92 and Its Combination With ISS in an Independent Cohort of Patients With Multiple Myeloma

Potential therapeutic and economic value of risk-stratified treatment as initial treatment of multiple myeloma in Europe

Genome-wide linkage scan in Dutch hereditary non-BRCA1/2 breast cancer families identifies 9q21-22 as a putative breast cancer susceptibility locus

Integration of DNA Copy Number Alterations and Prognostic Gene Expression Signatures in Breast Cancer Patients

Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations

Cross-species comparison of aCGH data from mouse and human BRCA1- and BRCA2-mutated breast cancers

Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket : a multi-modal approach

Retreat to make progress

Detection of mutant NPM1 mRNA in acute myeloid leukemia using custom gene expression arrays

Detection of CEBPA double mutants in acute myeloid leukemia using a custom gene expression array

The Prognostic Power of Gene Expression Profiling with Cytogentics and Routinely Acquired Serum Markers: SKY92 Combined with Revised ISS

High-Risk Multiple Myeloma Patients Are Missed without Gene Expression Profiling

The Combination of SKY92 and ISS Provides a Powerful Tool to Identify Both High Risk and Low Risk Multiple Myeloma Cases, Validation in Two Independent Cohorts

Validation of SKY92 high and low risk prognostication in a retrospective, multinational cohort of 155 non-trial multiple myeloma patients

Comprehensive Biologic Characterization of 99 Multiple Myeloma Patients Using Cytomorphology, FISH, Gene Expression Profiling and Mutation Screening Leads to Important Clinical and Therapeutic Insights

Suchergebnisse filtern